Treatment strategy and therapy based on immune response in patients with gastric cancers

Abstract

In this editorial, we highlight the significance of a retrospective study “Analysis of the impact of immunotherapy efficacy and safety in patients with gastric cancer and liver metastasis” performed by Liu et al . The authors utilized data collected from gastric cancer (GC) patients and assessed immunotherapy effectiveness and survival status. They found significant differences in treatment response. Because immunotherapy seems to be a beneficial strategy for advanced GC patients, stratification of the data based on metastasis status may further improve treatment strategies.